In vitro gene expression profiling with isolated hepatocytes has been used to assess the hepatotoxicity of certain chemicals because of animal welfare issues. However, whether an in vitro system can completely replace the in vivo system has yet to be elucidated in detail. Using a focused microarray established in our laboratory, we examined gene expression profiles in the mouse liver and primary cultured hepatocytes after treatment with different doses of acetaminophen, a widely used analgesic that frequently causes liver injury. The acute hepatotoxicity of acetaminophen was confirmed by showing the induction of an oxidative stress marker, heme oxygenase-1, elevated levels of serum transaminase, and histopathological findings. In vivo microarray and network analysis showed that acetaminophen treatment provoked alterations in relation to the inflammatory response, and that tumor necrosis factor-α plays a central role in related pathway alterations. By contrast, pathway analyses in in vitro isolated hepatocytes did not find such prominent changes in the inflammation-related networks compared with the in vivo situation. Thus, although in vitro gene expression profiles are useful for evaluating the direct toxicity of chemicals, indirect toxicities including inflammatory responses mediated by cell-cell interactions or secondary toxicity due to pathophysiological changes in the whole body may be overlooked. Our results indicate that the in vitro hepatotoxicity prediction system using isolated hepatocytes does not fully reflect the in vivo cellular response. An in vitro system may be appropriate, therefore, for high throughput screening to detect the direct hepatotoxicity of a test compound.
method for large-scale profiling of gene expression changes in biological samples. Previously, we developed a customized DNA microarray, designated as the mouse Liver Stress Array, and validated the effectiveness of the system (Inadera et al. 2008 (Inadera et al. , 2010 . This array contains important genes involved in detoxifying exogenous substances and sensing homeostasis in the liver. The advantages of microarray technology include the ability to characterize relationships between genes as well as changes in biological processes (Fukushima et al. 2006; Ganter et al. 2008) . The mechanistic analysis of xenobiotic toxicity can be facilitated using pathway analysis tools. Indeed, a systems biology approach has been used to analyze the complex data sets in a concise and integrated manner, with emphasis on the pathways involved (Ganter et al. 2008 ). In addition, our previous studies indicated that the combination of focused arrays and bioinformatics tools could help to analyze the mechanisms of chemical toxicity (Inadera et al. 2008 (Inadera et al. , 2010 .
Drug toxicity is principally assessed by animal studies. However, animal welfare issues represent a strong incentive to reduce testing in animals. The 3R concept, which is concerned with the reduction, refinement, and replacement of animal studies, has become the scientific basis of many institutions. Moreover, animal studies are resource-intensive in terms of time and cost, and require significant amounts of drugs. Therefore, in vitro methods are highly desirable because they have higher throughput, require much lower amounts of drugs, and reduce animal testing (Garle et al. 1994; Paillard et al. 1999) . However, whether an in vitro system can fully replace animal studies has yet to be elucidated in detail. In the present study, using our array system, we compared the expression profiles of liver genes, in vivo and in vitro, to gain further insights into the utility and limitations of in vitro hepatotoxicity prediction systems, using acetaminophen as a test compound.
Materials and Methods

Reagents
Acetaminophen was purchased from Wako Pure Chemicals (Osaka, Japan). Alamar Blue was purchased from Biosource International (Camarillo, CA). RNA later solution and the Oligotex-dT30 mRNA Purification kit were from Takara (Osaka, Japan). Trizol reagent was obtained from Invitrogen (Carlsbad, CA). Superscript III reverse transcriptase and mouse Cot-1 DNA were from Life Technologies (Rockville, MD). Fluorescent nucleotide Cy5-and Cy3-deoxyuridine triphosphates (dUTPs) were from Perkin-Elmer (Boston, MA). All other materials were from Sigma-Aldrich (St. Louis, MO), unless otherwise specified.
Animals and treatment procedures
Six-week-old male C57BL/6J mice (Sakyo Lab., Toyama, Japan) were used throughout the study. The mice were housed at a constant temperature, with a 12 h light/dark cycle, and under specific pathogen-free conditions in the animal center at University of Toyama. All animal procedures were performed in accordance with our institutional guidelines and were approved by the Animal Ethics Committee. The mice were acclimated for 1 week prior to use. After acclimation, the animals were randomly assigned to four groups (n = 5 in each group): a control group and three treatment groups. The acetaminophen solution was made in phosphate-buffered saline (PBS) at 20 mg/ml and was dissolved by heating in a water bath. The indicated doses of acetaminophen were administered to the peritoneal cavity of the mice. Control animals received an equal volume of PBS. Eight hours after injection, the mice were sacrificed, their blood was collected, and their livers were removed for pathological examination and gene expression analysis. The 8 hour interval between administration and sacrifice was determined based on previous studies (Hanczko et al. 2009; Shinohara et al. 2010) .
Measurement of serum transaminases
Blood samples were immediately collected in tubes, kept at room temperature for 1 h, and centrifuged at 1,000 g for 10 min to obtain serum. Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities were measured using a Transaminase CII-test kit (Wako Pure Chemicals), according to the manufacturer's protocol.
Preparation of primary cultures of mouse hepatocytes
The livers of mice were subjected to collagenase perfusion followed by Percoll isodensity centrifugation for the isolation of viable hepatocytes, using a previously described method (Nemoto et al. 1989) . Briefly, the cells were dispersed in Leibovitz L-15 medium containing bovine serum albumin (2 g/liter), insulin (5 mg/liter), transferrin (5 mg/liter), selenium (5 µg/liter), and dexamethasone (4 µg/liter) at a density of 0.3 to 1.0 × 10 6 mouse cells/ 4 ml/ 60-mm dish; these cells were allowed to seed in the dishes. The cultures were maintained at 37°C in a humidified incubator. The non-attached cells were discarded by aspiration, followed by medium exchange approximately 2 h after seeding. The viability of cells following treatment with acetaminophen was determined using the Alamar Blue assay (Nociari et al. 1998) . The effects of acetaminophen were evaluated over a 24 h period, because the acute toxicity of acetaminophen is prominent at this point (Wang et al. 2002; Suzuki et al. 2008) .
Histopathological examination
The livers were immediately removed and cross-sectioned into small pieces. Each piece was fixed in 10% buffered formalin, dehydrated in graded ethyl alcohol, and embedded in paraffin. Four micrometer-thick sections were stained with hematoxylin/eosin (H/E). Histopathological assessment of the H/E-stained sections was performed using a light microscope. Immunohistochemical staining of heme oxygenase (HO)-1 was conducted as described previously (Babu et al. 2007 ).
Microarray hybridization
Our cDNA microarray, the mouse Liver Stress Array ver. 2.0, contained 399 cDNAs (Inadera et al. 2010 ). This array system contains major liver-related proteins based on the liver transcriptome, cDNAs encoding proteins affecting drug metabolism, inflammationrelated proteins, responsive-genes of xenobiotic receptors, stressresponsive genes, and apoptosis-related genes (Inadera et al. 2008 (Inadera et al. , 2010 .
RNA isolation and microarray hybridization were principally performed as described previously (Inadera et al. 2008) . Briefly, the dissected livers were immediately soaked in RNA later solution to prevent RNA degradation. Total RNA was isolated from the livers using Trizol reagent, from which mRNA was enriched using the Oligotex-dT30 mRNA Purification kit. Fluorescently-labeled cDNA probes were created from 1 µg aliquots of the mRNA samples by oligo(dT)-primed reverse transcription using Superscript III reverse transcriptase. Fluorescent nucleotide Cy5-and Cy3-dUTPs were used to label the cDNAs of the experimental and reference tissues, respectively. We selected a two-fold threshold as the cutoff for significance. Microarray data analyses were performed using the GeneSpring software (Silicon Genetics, Redwood City, CA). Realtime polymerase chain reaction (PCR) was performed as described previously (Inadera et al. 2008) .
Ingenuity Pathways Analysis (IPA)
To examine the gene ontology, the Ingenuity Pathways Knowledge Base software (Ingenuity Systems, Mountain View, CA) was used to analyze significant interactions. Ingenuity Pathways Knowledge Base is a database that contains individually curated relationships between gene objects to generate significant biological networks and pathways. The backbone of the system is a knowledge base that contains information extracted from the academic literature, which is used for functional data analysis and network generation. A significance score (p value) for each network and/or canonical pathway is calculated according to the fit of the test gene versus genes in each particular pathway. The score for each identified network is calculated as the negative log p value, which indicates the likelihood that the genes in a list of test genes can be found together in a network by random chance.
Statistical analysis
All comparisons were made by analysis of variance with post hoc testing. All calculations and analyses were performed using the Stat-View software (SAS Institute Inc., Cary, NC); p values less than 0.05 were considered to be statistically significant, and such differences are indicated in the figures by asterisks.
Results
Clinicopathological and histopathological data
Acetaminophen provokes oxidative stress in the liver and induces anti-oxidant molecules (Yoshikawa et al. 2009 ). HO-1 is a phase II enzyme having anti-oxidant properties; it is transcriptionally regulated by a large variety of oxidative stresses (Paine et al. 2010) . Induction of HO-1 expression, therefore, represents an adaptive response that increases cell resistance to oxidative injury. We first examined whether acetaminophen induces HO-1 using real-time PCR and immunohistochemistry. The results showed that single doses of acetaminophen induced HO-1 mRNA in a dose-dependent manner (Fig. 1A) . Immunohistochemical staining confirmed HO-1 induction (Fig. 1B) . Control animals and those administered with 5 and 50 mg/kg of acetaminophen exhibited minimal to non-detectable levels of HO-1. By contrast, mice administered with 500 mg/kg of acetaminophen exhibited extensive localized staining of hepatocytes within the pericentral regions of the liver lobule. Thus, our system effectively reflected the effects of acetaminophen on the liver.
Increases in AST and ALT activities were prominent following treatment with 500 mg/kg of acetaminophen, whereas no changes were observed after the administration of 5 and 50 mg/kg of acetaminophen (Fig. 1C) . Liver histopathology indicated that the high dose of acetaminophen (500 mg/kg) was hepatotoxic, while the two lower doses induced no morphological changes (Fig. 1D ). Extensive cell necrosis and development of an inflammatory response were observed after the administration of 500 mg/kg of acetaminophen.
Microarray analysis
Microarray techniques can identify subtle changes at lower doses that would not be observed by conventional toxicological criteria, such as abnormal clinical chemistry and histopathology (Heinloth et al. 2004; Toyoshiba et al. 2006) . Therefore, we studied the effects of the different doses of acetaminophen on gene expression profiles using in-house microarrays. The correlation-based hierarchical clustering of the genes affected by acetaminophen is depicted in Fig. 2 . Hierarchical clustering revealed clear patterns of expression changes across different dose points. Doses as low as 5 mg/kg induced significant gene expression changes, probably because the genes included in our array were specifically selected to detect subtle changes in relation to early damage in the liver (Inadera et al. 2008 (Inadera et al. , 2010 . These results confirm that gene expression signatures can potentially serve as useful and sensitive indicators of drug toxicities. In this experiment, the highest number of gene expression changes, and the highest fold induction, were observed following treatment with 500 mg/kg of acetaminophen (Fig. 2) .
Pathways analysis
Pathway analysis technology allows the mapping of gene expression data into relevant pathway maps, based on their functional annotation and known molecular interactions. To clarify the biologically relevant networks and functional categories of genes identified in the array system, we performed pathway and functional category analyses on the up-and down-regulated gene clusters, using the Ingenuity Pathways Knowledge Base with conditions of 500 mg/kg of acetaminophen treatment. IPA reveals significant alterations in certain biological networks and enables us to obtain a molecular understanding of the mechanism by which acetaminophen leads to cell injury in mouse livers. The most significant network of acetaminophenresponse genes identified by IPA was the inflammationrelated pathway. Indeed, interaction network analysis using IPA showed a network of genes related to the inflammatory response (cellular movement, hematological system development and function, and immune response) as the most significant (score = 60, with 34 differentially expressed genes) (Table 1) . Moreover, our results indicated that tumor necrosis factor (TNF)-α may have a central role in related pathway alterations that were highly activated following treatment with 500 mg/kg of acetaminophen (Fig.  3) .
In vitro culture analysis
We prepared primary cultured hepatocytes and treated them with 0.1 mM-10 mM of acetaminophen. First, we determined the cellular toxicity provoked by acetaminophen using the Alamar Blue assay. As shown in Fig. 4A , acetaminophen treatment produced a concentration-dependent reduction in Alamar Blue incorporation. Thus, acetaminophen treatment was observed to damage the cells in a dosedependent manner. Next, HO-1 induction was evaluated by real-time PCR analysis. Although treatment with 0.1 mM and 1 mM acetaminophen induced HO-1 expression, 10 mM acetaminophen dramatically reduced HO-1 expression (Fig. 4B) . Following the 10 mM acetaminophen treatment, many of the cells detached from the culture dishes, probably as a result of necrotic cell death.
The correlation-based hierarchical clustering of the genes affected by acetaminophen according to microarray analysis is depicted in Fig. 4C . Treatment with 0.1 mM acetaminophen induced the most dramatic changes in the gene expression of the three concentrations tested. At this dose, interaction network analysis using IPA showed that a network of inflammation-related pathways (cellular movement, immune cell trafficking, and antigen presentation) was the most significant, although the score (score = 44, with 27 differentially expressed genes) was less significant than that obtained for the in vivo analysis (Table 1) . Moreover, the affected genes in the molecular network were not the same as those detected in the in vivo analysis (Table  1) .
Discussion
Acetaminophen is directly cytotoxic to hepatocytes as a result of its conversion to the reactive intermediate, N-acetyl-p-benzoquinone imine (NAPQI) (Gunawan and Kaplowits 2007) . NAPQI is not harmful if it combines rapidly with glutathione; however, when hepatic glutathione stores are depleted, NAPQI escapes detoxification, resulting in hepatocyte death (Jaeschke and Bajt 2006) . Furthermore, acetaminophen overdose triggers mitochondrial dysfunction by inhibiting mitochondrial respiration and causing a decline in ATP levels (Burcham and Harman 1991) , eventually inducing mitochondrial oxidant stress (Bajt et al. 2004 ). Thus, acetaminophen toxicity causes the production of reactive oxygen species, leading to oxidative stress (James et al. 2003) . Consistent with this, our results indicated that APAP induces an oxidative stress marker, HO-1.
Acetaminophen is a widely used analgesic but acute overdose is a frequent cause of liver failure. The conventional daily oral dose of acetaminophen is 325-1,000 mg; the maximum daily recommended dose is 4,000 mg or 66-77 mg/kg in adults (Brunton et al. 2010) . For children, a dose of 10 mg/kg is generally used. In adults, hepatotoxicity may occur after the ingestion of a single dose of 150-250 mg/kg of acetaminophen (Brunton et al. 2010) . Although the metabolism and effects of acetaminophen in humans and rodents are not the same, our transcriptome analysis provides some information relating to the toxic mechanism of acetaminophen. Our results showed that treatment with 5 mg/kg of acetaminophen induced the expression of several genes, up-regulating Sth2 (sulfotranseferase, hydroxysteroid preferring 2), Cmkbr1l1 (chemokine receptor 1-like1), and Cmkbr5 (chemokine receptor 5). The expression changes of these genes may be adaptive responses to xenobiotics in the liver. By contrast, at a toxic dose of 500 mg/kg, acetaminophen changed the expressions of several inflammation-related genes; a typical example is depicted in Fig. 3 .
The initial event in acetaminophen-induced hepatotoxicity is a toxic metabolic injury leading to hepatocyte death by necrosis and apoptosis. This results in secondary activation of the innate immune response, involving up-regulation of inflammatory cytokines (Liu et al. 2004 ). The physiological purpose of inflammation is to re-establish a homeostatic state that entails resolution of the acetaminopheninduced stress. Macrophages act as the first responders to tissue damage by producing a panel of proinflammatory cytokines, such as TNF-α and interleukin (IL)-1. Resident Kupffer cells (liver-specific macrophages) comprise about 5% of the total cell mass, and their anatomical position in the sinusoidal spaces of the liver allows them to act as immune sentinels for portal and systemic circulations. Moreover, infiltrated neutrophils can release a number of proteases and generate superoxide anion radicals through Mice were treated with the indicated doses of acetaminophen, and gene expression was monitored using in-house cDNA microarrays. Clustering was performed using the GeneSpring software. Each row denotes a single gene, and each column represents an individual dose. The color scale represents a fold-change in intensity observed in the microarray experiments. Intensity in the green and red color ranges indicates down-regulated and up-regulated probe sets, respectively. Intensity in the black color range indicates no change (relative expression, 1). Analyses were performed using the Ingenuity Pathways Analysis (IPA) software. IPA is a computational tool that uses the data at hand and existing knowledge on linked genes to find, but not quantify, networks that may be impacted. The biological functions are ranked according to the significance of the biological function to that network. The score is derived from a p value, and scores of 2 or more are associated with at least 99 % confidence of not being generated by random chance.
List of abbreviations used for Ingenuity Pathways Analysis. ABCC2, ATP-binding cassette, sub-family C (CFTR/MRP), member 2; AK2, adenylate kinase 2; AKR1C4, aldo-keto reductase family 1, member C4; ALAD, aminolevulinate dehydratase; ALDH, aldehyde dehydrogenase; ALPL, alkaline phosphatase, liver/bone/kidney; ALT, ADP-ribosyltransferase; B4GALNT1, beta-1,4-N-acetyl-galactosaminyl transferase 1; B4GALT1, betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 1; CCL, chemokine (C-C motif) ligand; CCR, chemokine (C-C motif) receptor; COX5A, cytochrome c oxidase subunit Va; Cpla2, cytosolic phospholipase a2; CSF, colony stimulating factor; CSF2R, colony stimulating factor 2 receptor; CSF3, colony stimulating factor 3; CSF3R, colony stimulating factor 3 receptor; CX3CR, chemokine (C-X3-C motif) receptor; CXCL, chemokine (C-X-C motif) ligand; CYP, cytochrome P450; DARC, Duffy blood group, chemokine receptor; DBT, dihydrolipoamide branched chain transacylase E2; Fcgr1, Fc receptor, IgG, high affinity I; Fcgr3, Fc receptor, IgG, low affinity III; FKBP5, FK506 binding protein 5; FMO, flavin monooxygenase; GNPAT, glyceronephosphate O-acyltransferase; GST, glutathione S-transferase; HPRT1, hypoxanthine phosphoribosyltransferase 1; HSD17B, hydroxysteroid (17-beta) dehydrogenase; IL, interleukin; LCAT, lecithin-cholesterol acyltransferase; LTA, lymphotoxin alpha; MGMT, O-6-methylguanine-DNA methyltransferase; NfkB, nuclear factor kappa B; NNMT, nicotinamide N-methyltransferase; NOS2, nitric oxide synthase 2, inducible; NPR1, natriuretic peptide receptor 1; OAT, ornithine aminotransferase; p70S6k, p70 S6 kinase; PC, pyruvate carboxylase; Pdgf, platelet-derived growth factor beta; PDK2, pyruvate dehydrogenase kinase, isozyme 2; PLA2, phospholipase A2; PXR, pregnane X receptor; SEPP1, selenoprotein P, plasma, 1; Sod, superoxide dismutase; Sphk, sphingosine kinase; SRM, spermidine synthase; STAT, signal transducer and activator of transcription; TGFB, transforming growth factor, beta; Timp, Tissue inhibitor of metalloproteases; TNF, tumor necrosis factor; TPMT, thiopurine S-methyltransferase; TPST, tyrosylprotein sulfotransferase; WDFY3, WD repeat and FYVE domain containing 3; XCL1, chemokine (C motif) ligand 1; and XCR1, chemokine (C motif) receptor 1. Pathway analysis of the up-and down-regulated genes was performed using the Ingenuity Pathways Analysis Knowledge Base, with results from the 500 mg/kg acetaminophen treatment experiments. These networks describe the functional relationships between gene products, based on known interactions reported in the literature. Green indicates down-regulation, and red indicates up-regulation, with a more intense color indicating a greater change. Nodes and edges are displayed with various shapes and labels that represent the functional class of the genes and the nature of the relationship between the nodes, respectively. The pathways least likely to have occurred by chance are presented. List of abbreviations used for Ingenuity Pathways Analysis. AK2, adenylate kinase 2; ALDH1A3, aldehyde dehydrogenase 1 family, member A3; CCL7, chemokine (C-C motif) ligand 7; CCL8, chemokine (C-C motif) ligand 8; CCL11, chemokine (C-C motif) ligand 11; CCL27, chemokine (C-C motif) ligand 27; CCR2, chemokine (C-C motif) receptor 2; CCR3, chemokine (C-C motif) receptor 3; CCR5, chemokine (C-C motif) receptor 5; CCR10, chemokine (C-C motif) receptor 10; CXCL9, chemokine (C-X-C motif) ligand 9; CXCL11, chemokine (C-X-C motif) ligand 11; CXCL16, chemokine (C-X-C motif) ligand 16; CXCR3, chemokine (C-X-C motif) receptor 3; CXCR6, chemokine (C-X-C motif) receptor 6; CXCR7, chemokine (C-X-C motif) receptor 7; DBT, dihydrolipoamide branched chain transacylase E2; GSTT1, glutathione S-transferase theta 1; IL1/IL6/TNF, interleukin 1/ interleukin 6/ tumor necrosis factor; IL2RG, interleukin 2 receptor, gamma; IL4R, interleukin 4 receptor; IL7R, interleukin 7 receptor; IL12A, interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); IL13RA1, interleukin 13 receptor, alpha 1; IL13RA2, interleukin 13 receptor, alpha 2; IL15RA, interleukin 15 receptor, alpha; IL21RA, interleukin 21 receptor, alpha; Il9, interleukin 9; Il9R, interleukin 9 receptor; NNMT, nicotinamide N-methyltransferase; PC, pyruvate carboxylase; PLA2G7, phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma); TNF, tumor necrosis factor; and TPST1, tyrosylprotein sulfotransferase 1.
the enzyme nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. The activation of Kupffer cells is an important source of acetaminophen-induced inflammatory mediators, such as IL-1β, TNF-α, IL-6, and IL-8 (Bauer et al. 2000; Dambach et al. 2002 Dambach et al. , 2006 . Thus, in in vivo analysis, a prominent high score for inflammation-related networks, which was accompanied by acetaminophen hepatotoxicity, appears probable. The predominance of hepatocytes in the liver has led to them being viewed as an appropriate cell type for in vitro studies. Indeed, in vitro hepatotoxicity prediction systems using primary cultured hepatocytes have been used to elucidate the direct effects of compounds (Garle et al. 1994; Paillard et al. 1999) . However, in vitro toxicity systems cannot fully reflect the in vivo expression profile, as observed in our study. There are several possible explanations for the different responses observed in vivo and in vitro. First, when cells are cultured using a single cell type, there are no opportunities for interactions with other cell types. Although hepatocytes represent the most abundant cell type and fulfill most of the main functions in the liver, other cell types, such as Kupffer cells, stellate cells, blood macrophages, and other inflammatory cells also exist in the liver. Therefore, the lower score for inflammatory path- ways obtained in vitro compared with in vivo may imply that other cell types also play a role in provoking the inflammatory response in the mouse liver. Nonparenchymal cells and infiltrating inflammatory cells may be involved in this inflammatory response. Indeed, a previous study suggested that Kupffer cells may play a role in acetaminopheninduced liver injury (Michael et al. 1999) . Second, in hepatocyte cultures, the three-dimensional architecture and the extracellular matrix are largely lost. Third, in vivo, compounds are metabolized, distributed, and eliminated from the body. By contrast, in the in vitro system, compounds affect the cells directly and continuously until the compound-containing medium is removed. Moreover, systemic influences such as neuronal and hormonal regulation do not take place in vitro. Fourth, primary hepatocytes have been reported to lose their physiological capacity. For example, endogenous farnesoid X receptor (FXR) mRNA and protein levels decline by more than 90% compared with the intact liver within 1 day of isolation of primary hepatocytes (Lee et al. 2010) . In summary, our results suggest that an in vitro hepatotoxicity prediction system using primary cultured hepatocytes dose not fully reflect the in vivo expression profile and cellular function. Although in vitro gene expression profiling is useful for evaluating the direct toxicity of chemicals, indirect toxicities mediated by other cells or secondary toxicity due to pathophysiological changes in other organs may be overlooked. It may be obvious that an in vitro system using primary hepatocytes cannot detect the toxicity associated with multiple cellular populations. However, if comparisons of in vivo expression profiling are made with in vitro expression profiling, it may be possible to estimate the contribution of multi cellular components toward hepatotoxicity. Thus, an in vitro system may be appropriate, for example, to detect the direct effects of early stage hepatotoxicity for high throughput screening, and it has the potential to act as a short-term screening system for obtaining an early overview of the hepatotoxic mechanism of a new compound.
